BPG is committed to discovery and dissemination of knowledge
Citation
Xu LX, Yuan JJ, Xue R, Zhou J. Nab-paclitaxel plus capecitabine as first-line treatment for advanced biliary tract cancers: An open-label, non-randomized, phase II clinical trial. World J Gastroenterol 2024; 30(30): 3564-3573 [PMID: 39193574 DOI: 10.3748/wjg.v30.i30.3564]
Please LOGIN to submit a new comment.